Five‐year on‐treatment variables‐based PPACS model predicts subsequent hepatocellular carcinoma in entecavir/tenofovir‐treated patients

医学 恩替卡韦 肝细胞癌 肝硬化 内科学 胃肠病学 回顾性队列研究 肿瘤科 临床终点 置信区间 乙型肝炎 慢性肝炎 临床试验 免疫学 病毒 拉米夫定
作者
Yeonjung Ha,Ji Hyae Lim,Young Eun Chon,Mi Na Kim,Joo Ho Lee,Kang Mo Kim,Ju Hyun Shim,Danbi Lee,Seong Gyu Hwang,Seungbong Han,Han Chu Lee
出处
期刊:International Journal of Cancer [Wiley]
卷期号:153 (12): 2045-2054 被引量:2
标识
DOI:10.1002/ijc.34704
摘要

Abstract Considering the lower risk of hepatocellular carcinoma (HCC) in chronic hepatitis B (CHB) patients receiving long‐term potent antiviral therapy, models predicting HCC after 5 years of therapy are needed. We conducted a multicenter retrospective cohort study to construct and validate a model predicting HCC after 5 years of entecavir (ETV) or tenofovir (TFV) therapy for CHB. The endpoint was HCC after 5 years of ETV/TFV therapy. Information on age, sex, liver cirrhosis (assessed by diagnosis code and confirmed by clinical findings) and type of antiviral agent was obtained at baseline (initiation of ETV/TFV). Laboratory values were collected at baseline and 5 years. Risk factors for HCC were identified in the training set and the final prediction model was validated using the test set. Among 7542 patients, 345 (4.6%) developed HCC after 5 years of ETV/TFV therapy. HCC risk after 5 years of ETV/TFV therapy was increased by 4‐fold in patients with liver cirrhosis than in those without cirrhosis at baseline. Furthermore, P latelet counts and P rothrombin time at 5 years, A ge at baseline and S ex were associated with risk of HCC and were incorporated into a prediction model, PPACS. PPACS showed a good performance with a time‐dependent area under the curve of 0.80 (95% confidence interval, 0.75‐0.85) at 8‐year of ETV/TFV therapy, a Brier score of 0.031 and an integrated Brier score of 0.006 in the test set. In conclusion, the PPACS model provides a reliable assessment of HCC risk after 5 years of ETV/TFV therapy ( https://ppacs.shinyapps.io/shiny_app_up/ ).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
1秒前
所所应助小鱼儿采纳,获得10
2秒前
ruclinwe发布了新的文献求助10
2秒前
2秒前
Brucewang1127发布了新的文献求助10
2秒前
3秒前
bkagyin应助坦率芝麻采纳,获得10
3秒前
猹尔斯发布了新的文献求助10
3秒前
搜集达人应助见雨鱼采纳,获得30
4秒前
imi发布了新的文献求助30
4秒前
4秒前
5秒前
清爽老九发布了新的文献求助10
5秒前
zoye完成签到,获得积分10
5秒前
Rondab应助wgt采纳,获得10
5秒前
风趣的老太应助cx330采纳,获得10
5秒前
LJQ发布了新的文献求助30
6秒前
852应助guard采纳,获得10
6秒前
阮楷瑞发布了新的文献求助10
7秒前
勤劳的鸡发布了新的文献求助10
7秒前
桐桐应助Wang采纳,获得10
8秒前
Crayon完成签到,获得积分10
8秒前
8秒前
9秒前
樱悼柳雪发布了新的文献求助10
9秒前
今后应助hhh采纳,获得10
9秒前
HHR33发布了新的文献求助10
9秒前
limz完成签到,获得积分10
9秒前
10秒前
10秒前
r2333发布了新的文献求助10
10秒前
11秒前
亮白的萝卜完成签到 ,获得积分10
11秒前
12秒前
JamesPei应助梓歆采纳,获得10
12秒前
杨小绿zbsl发布了新的文献求助10
12秒前
12秒前
无名完成签到,获得积分10
13秒前
高分求助中
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
Effective Learning and Mental Wellbeing 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3974602
求助须知:如何正确求助?哪些是违规求助? 3519026
关于积分的说明 11196787
捐赠科研通 3255127
什么是DOI,文献DOI怎么找? 1797693
邀请新用户注册赠送积分活动 877100
科研通“疑难数据库(出版商)”最低求助积分说明 806130